Agonist Of Ppar-Gamma Reduced Epithelial-Mesenchymal Transition In Eosinophilic Chronic Rhinosinusitis With Nasal Polyps Via Inhibition Of High Mobility Group Box1

Pingli Yang,Shan Chen,Gang Zhong,Weijia Kong,Yanjun Wang
DOI: https://doi.org/10.7150/ijms.35936
2019-01-01
International Journal of Medical Sciences
Abstract:Epithelial-mesenchymal transition (EMT) has been reported to occur in eosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP). Among the cytokines that cause EMT, high mobility group box 1 (HMGB1) has been shown to give rise to EMT in airway epithelial cells. However, the mechanism of HMGB1-induced EMT in ECRSwNP is unknown. We explored the mechanism and possible inhibitor. Immunohistochemistry (IHC), immunofluorescence (IF), and western blot assay were used to detect the expression and location of HMGB1, peroxisome proliferator-activated receptor-gamma (PPAR-gamma), and EMT markers in eighteen ECRSwNP and twelve normal nasal mucosa tissues. Epithelial cells isolated from ECRSwNP were cultured with various doses of recombinant human HMGB1 (rhHMGB1) to study the expression of PPAR-gamma, and EMT markers. Additionally, the ligand of PPAR-gamma was incubated with epithelial cells to interfere with the effects of lipopolysaccharide (LPS) or rhHMGB1 to explore the effect on expression of HMGB1 and EMT markers. These results suggest that HMGB1 was highly expressed in ECRSwNP compared with its expression in control tissues, and EMT was also found highly in ECRSwNP compared with control tissues. Moreover, the cytoplasmic accumulation of HMGB1 in ECRSwNP was obvious compared with normal tissues. We also found dose-dependent induction by rhHMGB1 of up-regulation of N-cadherin and vimentin and down-regulation of ZO-1 and E-cadherin in epithelial cells isolated from ECRSwNP. The agonist of PPAR-gamma not only reduced release of HMGB1 induced by LPS, but also reversed the EMT. The protective role of PPAR-gamma also appeared in cells that had been incubated with rhHMGB1. In the current study, we discovered that the agonist of PPAR-gamma has a potential role in inhibited HMGB1-induced EMT in ECRSwNP. The agonist of PPAR-gamma may contribute to inhabit epithelial cells to become mesenchymal-like cells which play an important role in the pathogenesis of ECRSwNP.
What problem does this paper attempt to address?